HAMPTON, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Celldex announced today the presentation of histology data from the Company’s ongoing Phase 2 study of barzolvolimab in eosinophilic esophagitis ...

An international panel selected by the American College of Chest Physicians released recommendations for the noninvasive measurement of airway inflammation and management of cough due to asthma or ...

ATS 2025: Tezepelumab reduces COPD exacerbations in eosinophilic patients, ... These findings underscore the role of type 2 inflammation, particularly in the context of chronic bronchitis, ...